Table 1.
Characteristics of the 110 localized prostate cancer patients
| Characteristic | No. of patients (%) | |
|---|---|---|
| Age |
52–79 (median 70.0) |
|
| Risk group |
Low |
16 (14.5%) |
| Intermediate |
46 (41.8%) |
|
| High |
48 (43.6%) |
|
| T-Stage (UICC 6th) |
T1c-T2a |
81 |
| T2b |
10 |
|
| T3a-T3b |
19 |
|
| Initial PSA value |
<10 ng/mL |
60 (54.5%) |
| 10–19.9 ng/mL |
26 (23.6%) |
|
| ≥20 ng/mL |
24 (21.8%) |
|
| Gleason score |
5–6 |
33 (30.0%) |
| 7 |
41 (37.3%) |
|
| 8–10 |
36 (32.7%) |
|
| History of hormonal therapy |
(−) |
76 (69.1%) |
| (+) |
34 (30.9%) |
|
| Dose/fraction | 70 Gy/30 Fr(D95) |
101 |
| 75 Gy/30 Fr(Iso) |
5 |
|
| 65.3 Gy/28 Fr(D95) |
3 |
|
| 67.5 Gy/29 Fr(Iso) | 1 | |